Skip to content

Clinical application of three-dimensional reconstruction-based stepwise pulmonary resuscitation for intraoperative localization of small pulmonary nodules

Clinical application of three-dimensional reconstruction-based stepwise pulmonary resuscitation for intraoperative localization of small pulmonary nodules

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064474
Enrollment
Unknown
Registered
2022-10-09
Start date
2022-10-08
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung nodules

Interventions

Control group:Traditional lung recruitment strategy
Intervention group:Three-dimensional reconstruction-based stepped lung recruitment

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were to undergo surgery for pulmonary nodules. 2. Aged 18-80 years. 3. Diameter of pulmonary nodules <=2cm, pure ground glass/mixed/solid nodules. 4. ASA grade I-II.

Exclusion criteria

Exclusion criteria: 1. Refusing to sign informed consent. 2. Perioperative asthma attack. 3. Surgical contraindications, such as inability to tolerate anesthesia, distant metastasis, and bleeding tendency. 4. Pulmonary function examination suggested moderate to severe ventilation function and diffusion dysfunction.

Design outcomes

Primary

MeasureTime frame
nodule localization error;

Secondary

MeasureTime frame
pulmonary function assessment;blood gas index;duration of surgery;metablic equivalent;intraoperative lung resection volume;respiratory symptoms;hospital stay;medical cost;ECOG score;stair climb power test;

Countries

China

Contacts

Public ContactZhao Jing

China-Japan Friendship Hospital

zhaojing1009@aliyun.com+86 10 84205876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026